EA201890477A1 - Инкапсулированная композиция финголимода - Google Patents

Инкапсулированная композиция финголимода

Info

Publication number
EA201890477A1
EA201890477A1 EA201890477A EA201890477A EA201890477A1 EA 201890477 A1 EA201890477 A1 EA 201890477A1 EA 201890477 A EA201890477 A EA 201890477A EA 201890477 A EA201890477 A EA 201890477A EA 201890477 A1 EA201890477 A1 EA 201890477A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
fingolimoda
incapsulated
pharmaceutically acceptable
auxiliary substance
Prior art date
Application number
EA201890477A
Other languages
English (en)
Inventor
Али Тюркйылмаз
Сибель Зенгинер
Явуз Дедеоглу
Гёксу Яг
Эркин Озтюрк
Original Assignee
Сановел Иладж Санайи Ве Тиджарет А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сановел Иладж Санайи Ве Тиджарет А.С. filed Critical Сановел Иладж Санайи Ве Тиджарет А.С.
Publication of EA201890477A1 publication Critical patent/EA201890477A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к фармацевтической инкапсулированной композиции, содержащей финголимод или его фармацевтически приемлемые соли, вспомогательное вещество производных целлюлозы и по меньшей мере одно фармацевтически приемлемое вспомогательное вещество.
EA201890477A 2015-09-18 2016-09-16 Инкапсулированная композиция финголимода EA201890477A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201511720 2015-09-18
PCT/EP2016/071997 WO2017046345A1 (en) 2015-09-18 2016-09-16 Fingolimod capsule composition

Publications (1)

Publication Number Publication Date
EA201890477A1 true EA201890477A1 (ru) 2018-08-31

Family

ID=56939940

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201890477A EA201890477A1 (ru) 2015-09-18 2016-09-16 Инкапсулированная композиция финголимода

Country Status (4)

Country Link
US (1) US20180250235A1 (ru)
EP (1) EP3143991B1 (ru)
EA (1) EA201890477A1 (ru)
WO (1) WO2017046345A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1009654B (el) * 2018-08-31 2019-11-18 Φαρματεν Α.Β.Ε.Ε. Φαρμακευτικο σκευασμα που περιλαμβανει εναν ανοσοτροποποιητικο παραγοντα και μεθοδος για την παρασκευη αυτου
JP7492370B2 (ja) * 2019-05-07 2024-05-29 沢井製薬株式会社 フィンゴリモド塩酸塩含有製剤及びフィンゴリモド塩酸塩含有製剤の製造方法
WO2024085821A1 (en) * 2022-10-21 2024-04-25 Ilko Ilac Sanayi Ve Ticaret A.S. Content uniformity of teriflunomid in pharmaceutical dosage forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604229A (en) 1992-10-21 1997-02-18 Yoshitomi Pharmaceutical Industries, Ltd. 2-amino-1,3-propanediol compound and immunosuppressant
GB9624038D0 (en) 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
EA028950B1 (ru) 2011-08-01 2018-01-31 Тева Фармасьютикал Индастриз Лтд. Способ получения фармацевтических композиций, содержащих финголимод
US20160128951A1 (en) * 2013-07-29 2016-05-12 Aizant Drug Research Solutions Pvt Ltd Pharmaceutical compositions of fingolimod
IN2013MU03428A (ru) * 2013-10-30 2015-07-17 Wockhardt Ltd
US20150141520A1 (en) * 2013-11-18 2015-05-21 Chandrasekhar Kandi Stabilized pharmaceutical compositions of fingolimod and process for preparation thereof

Also Published As

Publication number Publication date
WO2017046345A1 (en) 2017-03-23
EP3143991B1 (en) 2020-04-08
US20180250235A1 (en) 2018-09-06
EP3143991A1 (en) 2017-03-22

Similar Documents

Publication Publication Date Title
CY1121928T1 (el) Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
NI201500135A (es) Composición farmacéutica de hidrocloruro de s-ketamina
EA201890204A1 (ru) Антибактериальные соединения
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
TR201821116A2 (tr) POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
BR112017000730B8 (pt) Derivados de pirrolidinona como inibidores de metap-2, e medicamentos
UA116053C2 (uk) Застосування похідних бензоімідазолу-проліну
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201890534A1 (ru) Новые аннелированные феноксиацетамиды
EA201591717A1 (ru) Твердые формы гидрохлорида вемурафениба
BR112016028083A2 (pt) Composição oral farmacêutica de isotretinoina e seu processo de preparação
EA201890477A1 (ru) Инкапсулированная композиция финголимода
BR112018004291A2 (pt) composição farmacêutica incluindo dutasterida e formulação de cápsula compreendendo a mesma
BR112017024126B8 (pt) Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos
CY1120192T1 (el) Ενωσεις για την ενισχυση της γνωστικης λειτουργιας
EA201892837A1 (ru) Физиологически сбалансированные составы для инъекций, включающие фоснетупитант